Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjay Rastogi

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Therapeutic Advances in Cardiovascular Disease|December 12, 2013
Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal diseaseAnjay Rastogi
BMC Nephrology|July 20, 2013
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherenceAdrian Covic, Anjay Rastogi
Current Cardiology Reports|May 21, 2008
The cardiorenal connection in heart failureAnjay Rastogi, Gregg C Fonarow
Kidney International Supplements|March 29, 2021
Anemia management for home dialysis including the new US public policy initiativeAnjay Rastogi, Edgar V Lerma
Advances in Chronic Kidney Disease|July 3, 2007
The future of renal replacement therapyAnjay Rastogi, Allen R Nissenson
Clinical Journal of the American Society of Nephrology : CJASN|December 10, 2009
Technological advances in renal replacement therapy: five years and beyondAnjay Rastogi, Allen R Nissenson
Journal of Clinical Medicine|April 28, 2023
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney DiseaseAnjay Rastogi, James L Januzzi
Journal of Diabetes and Its Complications|June 25, 2023
Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitusAnjay Rastogi, Matthew R Weir
Expert Review of Clinical Pharmacology|April 3, 2023
Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysisAnjay Rastogi, Steven Fishbane, Edgar Lerma
Advances in Therapy|September 19, 2024
Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and JapanNavdeep Tangri, Anjay Rastogi, Tadashi Sofue
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Therapeutic Advances in Cardiovascular Disease|December 12, 2013
Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal diseaseAnjay Rastogi
BMC Nephrology|July 20, 2013
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherenceAdrian Covic, Anjay Rastogi
Current Cardiology Reports|May 21, 2008
The cardiorenal connection in heart failureAnjay Rastogi, Gregg C Fonarow
Kidney International Supplements|March 29, 2021
Anemia management for home dialysis including the new US public policy initiativeAnjay Rastogi, Edgar V Lerma
Advances in Chronic Kidney Disease|July 3, 2007
The future of renal replacement therapyAnjay Rastogi, Allen R Nissenson
Clinical Journal of the American Society of Nephrology : CJASN|December 10, 2009
Technological advances in renal replacement therapy: five years and beyondAnjay Rastogi, Allen R Nissenson
Journal of Clinical Medicine|April 28, 2023
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney DiseaseAnjay Rastogi, James L Januzzi
Journal of Diabetes and Its Complications|June 25, 2023
Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitusAnjay Rastogi, Matthew R Weir
Expert Review of Clinical Pharmacology|April 3, 2023
Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysisAnjay Rastogi, Steven Fishbane, Edgar Lerma
Advances in Therapy|September 19, 2024
Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and JapanNavdeep Tangri, Anjay Rastogi, Tadashi Sofue
Pageof 10